Home / Clinical Decision Support & Reference / AI Platform

AI Platform

by Exo Imaging · Based in United States → — AI Imaging. Human Impact.

Cardiology Pulmonology Radiology

Claim this tool

Is this the maker? Claim the company →

Leave this field empty

Correct company / maker

Company website (optional)

Anything else? (optional)

Subscription model

Regulatory Status Disclosed

Overview

Exo Imaging’s AI Platform is a comprehensive suite of artificial intelligence tools integrated with their high-performance handheld ultrasound system, Exo Iris, and workflow solution, Exo Works. Designed to modernize medical imaging, the platform provides real-time AI and quality assurance for whole-body ultrasound examinations, aiming for zero complexity in clinical workflows.

The platform includes advanced AI applications such as SweepAI for guided view capture and instant quality feedback, and Exo U for AI scan tutoring and anatomical labeling, facilitating easier image acquisition and interpretation. It offers FDA-cleared insights across various specialties, including a Cardiac AI Suite for conditions like heart failure, a Lung AI Suite for detecting pathologies such as B-lines and effusions, and Fluid Management AI for real-time assessment of IVC collapsibility and bladder volume.

Exo’s AI Platform 2.0 (AIP 2.0) is a software as a medical device (SaMD) that assists qualified users with image-based assessment in adult patients, simplifying workflow by helping healthcare providers evaluate, quantify, and generate reports for ultrasound images. It is built to empower healthcare professionals to make critical, real-time decisions, improve patient outcomes, and enhance diagnostic accuracy and efficiency, particularly in point-of-care settings.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

Real-time AI for ultrasound image assessment
Guided view capture and instant quality feedback (SweepAI)
Automated findings and scan-to-note automation (Exo Works)
AI Scan Tutor and anatomical labeling (Exo U)
Cardiac AI Suite (LVEF estimation, heart failure, hypertrophy)
Lung AI Suite (B-lines, effusions, consolidations, lung pathology)
Fluid Management AI (IVC collapsibility, bladder volume)
Population Health AI (research-ready diagnostic support)
DICOM, PACS, VNA, worklist integration
Secure cloud storage and exam viewer

Use Cases

Point-of-care ultrasound (POCUS)
Cardiac assessment (LVEF, heart failure)
Lung assessment (pneumonia, tuberculosis, effusions, consolidations)
Fluid management
Diagnostic support in remote and underserved areas
Training and education for ultrasound acquisition and interpretation

What Physicians Need to Know

Evidence Base

AI platforms leverage vast medical knowledge bases, including over 60 million peer-reviewed papers, curated evidence-based clinical content (e.g., from UpToDate), clinical trials, observational studies, meta-analyses, expert opinions, and real-world data. These systems can analyze multiple data sources simultaneously to generate comprehensive and dynamic guidelines.

Clinical Validation Studies

Rigorous, end-to-end validation processes are crucial, with continuous evaluation cycles post-deployment to ensure long-term accuracy and adaptation to dynamic clinical environments. Real-world data (RWD) and real-world evidence (RWE) are utilized for post-market performance evaluations, considering diverse patient populations and potential biases.

Alert Fatigue Management

AI-enhanced Clinical Decision Support Systems (CDSS) actively combat alert fatigue by analyzing extensive data to prioritize critical alerts and reduce false positives through contextual information. These systems can filter low-priority alarms and dynamically adjust alert thresholds based on a patient's condition, improving workflow efficiency.

Override Rate Data

AI platforms track override rates, which for traditional CDSS alerts have been as high as 90-96%. Logging both the original AI suggestion and the human decision, along with the rationale for the override, is essential. A low override rate (e.g., below 5%) could indicate automation bias, where clinicians over-rely on AI.

Drug Interaction Checking

AI platforms incorporate advanced drug interaction checking, often utilizing machine learning to analyze patterns across millions of real-world adverse event reports. This approach can significantly outperform traditional databases in sensitivity and reduce false positive rates, enhancing medication safety. Some systems integrate with established professional drug interaction databases.

Differential Diagnosis Support

AI tools provide rapid differential diagnosis support by generating ranked possibilities from natural-language patient presentations and linking them to supporting evidence. This capability helps clinicians reduce anchoring bias, surface less common conditions, and organize next steps efficiently.

Guideline Update Frequency

AI systems are designed to provide continuous updates and adapt to emerging medical knowledge and patient needs. This ensures that the clinical guidelines and recommendations provided are dynamic, current, and evidence-based.

Clinical Workflow Integration

AI platforms are engineered for seamless integration into existing Electronic Health Records (EHRs) and clinical workflows. They deliver real-time, context-aware insights at the point of care without disrupting the physician's process, often by summarizing charts, drafting notes, and highlighting critical information.

Decision Audit Trail

Comprehensive audit trails are a critical feature, documenting who performed an activity, what was done, when, where, and the reasoning behind decisions. This includes details like AI model versions, prompts used, source data, processing steps, confidence scores, and human reviewer IDs. All overrides, including the original AI suggestion and the clinician's rationale, are logged for accountability and compliance.

Physician Tip

Always use the AI platform as a complementary tool to enhance, not replace, your clinical judgment. Critically validate all AI-generated content, cross-referencing with authoritative sources and applying your expertise to every output. Understand the known limitations and potential biases of the AI tool. Inform patients about AI usage and obtain consent when appropriate. Continuously learn about AI advancements to leverage tools effectively and ensure patient safety and trust.

The AI platform is designed for seamless integration with Electronic Health Records (EHRs) and other healthcare IT systems (e.g., lab systems, telemedicine platforms) via APIs. This ensures real-time data exchange, interoperability, and a comprehensive view of patient information. Strong data quality and adherence to HIPAA compliance for secure data handling, encryption, and access controls are paramount for effective and trustworthy integration.

At a glance

Pricing Subscription model

Deployment Cloud Based

Details

Category	Clinical Decision Support & Reference, Radiology & Imaging AI
Pricing	Subscription model Exo Iris Essential Package: $4,999 (device) + $1,200/year (mandatory subscription after first year for Exo Works); Iris Connect: Get Quote; Iris Enterprise: Get Quote
Deployment	Cloud-based
Compliance
BAA Available	Unknown AI-estimated
HIPAA Compliant	Unknown AI-estimated
FDA Status	1 AI-estimated Exo AI Platform 2.0 (AIP 2.0) is a software as a medical device (SaMD) that helps qualified users with image-based assessment of ultrasound examinations in adult patients. It is FDA 510(k) cleared (K240953) for noninvasive processing of ultrasound images to detect, measure, and calculate relevant medical parameters of structures and function, and provides Quality Score feedback for echocardiography and lung ultrasound scans.
Integrations
EHR	Not specified
Specialties	Cardiology, Pulmonology, Radiology

What the Web Says

AI Platforms are rapidly transforming various industries, particularly healthcare, by automating tasks, improving efficiency, and enhancing decision-making. Physicians and healthcare IT professionals highlight their ability to reduce administrative burdens, improve documentation accuracy, and allow more focus on patient care. Tech reviewers and general users also praise their ease of use, comprehensive features, and ability to amplify human potential across diverse applications like marketing, content creation, and IT monitoring.

Overall: Positive

Strengths

Reduces administrative burden and automates tedious tasks, freeing up time for core responsibilities.
Improves documentation accuracy and compliance, especially in healthcare.
Enhances efficiency and workflow, leading to better operations management.
Offers comprehensive monitoring capabilities and proactive issue detection in IT environments.
Provides strong visual analysis, automation, and natural language processing for various data types.
Easy to use with intuitive interfaces and responsive customer support.

Limitations

Some platforms may have a steep learning curve during initial setup.
Limited built-in integrations compared to more mature competitors in some cases.
Potential for slower performance when handling large datasets or campaigns.
Reliance on transcription-based workflows may still require physician review for accuracy and nuance.
Pricing models can be clunky or expensive, especially for smaller teams or advanced features.
Occasional performance issues or delays in loading, particularly in live environments.

Based on reviews from: Sully.ai, Capterra, Forbes, G2, YouTube, DeepCura, Reddit, Medium, Gartner Peer Insights, Keebler Health, AI Tech Hub, TechRadar, Parse

Last updated: 2026-07-18

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate AI Platform

Clinical Value

Ease of Use

Integration

Support & Docs

Value for Money

Your Name *

Email *

Your Role

Specialty

Your Review * (min 50 characters)

Press & Coverage

UMass Chan Medical School

Groundbreaking new study shows real-time AI platform better at diagnosing cancer than biopsy

A new study published in Clinical Gastroenterology and Hepatology highlights the first-ever in-human trial of a real-time AI system that outperformed biopsies in diagnosing cholangiocarcinoma, or bile duct cancer. The AI platform, developed by Neil Marya, MD, analyzed video streams from cholangioscopies and achieved 87.8% accuracy, surpassing both standard sampling and visual assessment by experienced endoscopists.

2026-04

AI News

Bunkerhill raises $55M to scale agentic AI across health systems

Bunkerhill Health secured $55 million in Series B funding to expand its agentic AI platform, Carebricks, which aims to bridge the gap between AI models in research settings and their real-world application with live clinical data. The company emphasizes that its platform is already operational in hospital systems, with over 20 AI agents live at UTMB, demonstrating tangible benefits like early detection of critical conditions.

2026-07

Journal of Medical Internet Research

Big Tech and the Rise of Consumer-Facing Health AI Assistants

Major technology companies are increasingly developing consumer-facing health AI assistants, shifting from enterprise-only solutions to platforms that offer personalized health guidance. These tools, such as Alphabet/Verily's Verily Me and Anthropic's Claude for Healthcare, aim to expand access, reduce wait times, and lower healthcare costs, but also raise concerns about misdiagnosis and overreliance.

2026-04

AI Magazine

Top 10: AI Platforms in Healthcare

AI Magazine highlights the top 10 AI platforms in healthcare, including Microsoft Dragon Copilot for clinical documentation, AWS HealthLake for health data management, and Google Cloud Healthcare for large-scale analytics. These platforms are designed to reduce administrative burden, enhance diagnostic accuracy, and improve workflow efficiency across various healthcare settings.

2026-01

McGuireWoods

A Pathway for Clinical AI Developers Opens: FDA Clears First Software as a Medical Device With Patient-Facing LLM

The FDA recently cleared UpDoc Inc.'s Software as a Medical Device (SaMD) that incorporates patient-facing large language models, marking a significant regulatory pathway for clinical AI developers. This clearance, issued in December 2025, is for a type 2 diabetes medication management software that allows patients to interact with an AI agent for data entry and treatment plan instructions.

2026-07

Cooley

AI Chatbot's Medical Claims Draw Regulatory Scrutiny

A complaint filed by the Pennsylvania State Board of Medicine against Character Technologies, operator of Character.AI, highlights growing regulatory scrutiny over AI platforms making medical claims. This case raises questions about state licensing board enforcement, FDA oversight, and the accelerating wave of state legislation targeting AI in healthcare.

2026-06

Journal of Medical Internet Research

Artificial Intelligence Platform Architecture for Hospital Systems: Systematic Review

This systematic review examines artificial intelligence platform architectures for hospital systems, highlighting the need for system-level roadmaps and governance structures to scale AI pilot projects. Fragmented infrastructures, such as siloed PACS and LIS, are identified as challenges that hinder widespread AI implementation in healthcare.

2025-12

Stanford HAI

How To Build a Safe, Secure Medical AI Platform

Stanford Health Care launched the 'ChatEHR Platform,' a foundational set of capabilities that securely connect AI models with real-time clinical data within existing EHR workflows. This platform, which includes an AI chat interface called 'ChatEHR User Interface,' allows medical staff to query patient records while upholding strict privacy and security standards.

2025-10

Videos

Product demos, reviews, and walkthroughs for AI Platform.

I Built an AGI Supercomputer in My LIVING ROOM! exo labs | mac deepseek

SIZZLE-- SEE WHY RUBI IS THE HOTTEST AI TOOL OUT THERE!

Local AI has a Secret Weakness

View all on YouTube

Frequently Asked Questions

How can an AI platform practically assist me in my daily clinical practice?

AI platforms can significantly streamline administrative tasks such as clinical documentation through AI scribes, appointment scheduling, and medical billing and coding. Clinically, they support decision-making by aiding in diagnostics, personalizing treatment plans, and identifying patterns in vast patient data, ultimately aiming to enhance efficiency and improve patient outcomes.

What are the key compliance and data privacy concerns for AI platforms in healthcare, especially regarding HIPAA?

AI platforms processing Protected Health Information (PHI) must adhere strictly to HIPAA regulations, necessitating robust technical, administrative, and contractual safeguards. This includes having Business Associate Agreements (BAAs) with AI vendors, ensuring data de-identification where appropriate, and limiting PHI exposure to the minimum necessary to prevent breaches and maintain patient privacy.

What are the main limitations and ethical considerations I should be aware of when using AI in patient care?

Key limitations include the potential for algorithmic bias, a lack of transparency in how AI arrives at its conclusions (the 'black box' problem), and varying accuracy rates, particularly in complex or rare cases. Ethical considerations involve ensuring informed patient consent, upholding human accountability, and preventing the technology from eroding the essential patient-physician relationship.

What are the typical pricing models for healthcare AI platforms, and what costs should I anticipate?

Pricing models for healthcare AI platforms vary, ranging from fixed costs for smaller, well-defined projects to consumption-based models (e.g., per use or per image analyzed) and subscription-as-a-service (SaaS) with tiered features. Anticipated costs can range from tens of thousands for basic administrative tools to hundreds of thousands or even millions for comprehensive diagnostic or enterprise-level platforms, often with additional expenses for data preparation and integration.

Are there alternatives to a comprehensive AI platform if I only need specific AI functionalities for my practice?

Yes, physicians can opt for specialized AI tools focused on particular functionalities, such as dedicated AI scribes for documentation or clinical decision support systems, many of which offer free or freemium tiers. Additionally, many modern Electronic Health Record (EHR) systems are integrating AI features directly, and general-purpose AI models can be adapted for non-clinical administrative tasks.

How accurate and reliable are AI platforms in providing clinical diagnoses or treatment recommendations?

The accuracy and reliability of AI platforms in clinical settings depend heavily on the specific application, the quality of their training data, and the context of use. While some AI models demonstrate high accuracy in specific tasks like image analysis, physicians must critically evaluate all AI-generated outputs, as these tools are designed to augment, not replace, human clinical judgment.

What is my professional responsibility and liability when using AI platforms for patient care?

Physicians retain ultimate professional responsibility and liability for all clinical decisions made, even when utilizing AI platforms as assistive tools. It is imperative to critically review and validate AI-generated recommendations, ensure comprehensive informed patient consent regarding AI involvement in their care, and understand the inherent limitations of the technology to prioritize patient safety and well-being.

Compare AI Platform

DeepXray vs AI Platform

Clinical Decision Support & Reference Adjacent · 60/100

DeepXray focuses on AI-powered analysis of X-rays for chronic bone diseases like osteoarthritis and osteoporosis, providing automated measurements and progression monitoring. In contrast, Exo Imaging's AI Platform integrates…

Butterfly iQ/iQ+ Ultrasound System vs AI Platform

Clinical Decision Support & Reference Direct · 90/100

Both Butterfly iQ/iQ+ and Exo Imaging's AI Platform offer handheld, AI-powered ultrasound systems designed for point-of-care diagnostics. They are direct competitors, providing similar core functionalities like whole-body imaging,…

Butterfly iQ3 Ultrasound System vs AI Platform

Clinical Decision Support & Reference Direct · 90/100

Both the Butterfly iQ3 and Exo Imaging's AI Platform offer handheld, AI-powered ultrasound solutions for point-of-care diagnostics, making them direct competitors. While Butterfly iQ3 emphasizes whole-body imaging with…

SOZO vs AI Platform

Clinical Decision Support & Reference Adjacent · 65/100

SOZO and Exo Imaging's AI Platform are adjacent tools in healthcare AI, both offering clinical decision support and leveraging advanced technology for patient assessment. SOZO focuses on bioimpedance…